Zhang, H., Yang, Y., Li, J., Wang, M., Saravanan, K. M., Wei, J., . . . Sciences, S. o. B. (2021). A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro.
استشهاد بنمط شيكاغوZhang, Haiping, et al. A Novel Virtual Screening Procedure Identifies Pralatrexate As Inhibitor of SARS-CoV-2 RdRp and It Reduces Viral Replication in Vitro. 2021.
MLA استشهادZhang, Haiping, et al. A Novel Virtual Screening Procedure Identifies Pralatrexate As Inhibitor of SARS-CoV-2 RdRp and It Reduces Viral Replication in Vitro. 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.